Animal models have led to important discoveries in biomedical research; their utility to psychiatry and comparative neuroscience is less clear. Disorders of higher-order brain function, schizophrenia chief among them, have proven exceptionally elusive to model. Schizophrenia researchers are of two minds about the possibility of modeling the schizophrenia phenotype(s) in laboratory animals: at one and the same time they are both pessimistic and pragmatic. That is, they admit the discouraging difficulty of the task, and yet proceed, apparently undeterred, with putative animal models of schizophrenia, as if the criticisms that yield the pessimistic judgments simply do not matter. In this article, we survey the criticisms and evaluate their merits. We then ask: what would it mean to take seriously the claim that modeling schizophrenia in at least some non-human animals - namely, rodents - is doomed, futile, impossible? How would, and how should, schizophrenia research be undertaken were the current animal models rejected as simply inadequate to the task? Our aim is not to disparage sound research into the etiology, symptomatology, and treatment of schizophrenia, but rather to emphasize the scope of the gap between current and optimal research practices. We conclude with recommendations to reinvigorate the quest to understand, prevent, and treat schizophrenia.

More than 90 million Americans suffer from low health literacy levels that can lead to detrimental health practices. One of the greatest issues stemming from low health literacy is the misuse of medication, which results in 125,000 deaths per year and close to $200 billion dollars in health care funds (Ngoh 2009). With their implementation into neighborhood settings and consequently the everyday lives of individuals, pharmacies show potential in being great assets towards increasing health literacy on an individual and societal level. However, pharmacists must first be made aware of the opportunities and challenges that exist concerning this effort. Through a three step literature review and corresponding comparative analysis, the results of this study show that pharmacists should focus on four main areas: overall assessment of health literacy in a pharmacy setting, individualization and tailoring of health/ medication plans, development of verbal and written communication tools, and the pharmacist-patient relationship. Each area presents a set of opportunities and challenges that must be accounted for in order to design more effective initiatives and tools in the pharmacists' aim to increase health literacy.

Human genetic engineering, the manipulation of genomic DNA, is an up and coming field in which soon we will no longer be asking if we can do it, but should we do it? It raises ethical questions regarding autonomy, the concept that an individual is capable of self-governance and making informed decisions, as well as consent of those who undergo genetic manipulation. Along with the ethical questions come issues of equality, equal opportunity of usage, and responsibility of those who use such technologies. The benefits and consequences of genetically engineering humans must be examined, such as the eradication of genetic diseases and the ability to alter ourselves as we desire, as well as the possible unintended outcomes, such as a two-class society and insurmountable inequality. Eugenics and the Transhumanism movement will also be examined, and how they could affect genetic engineering. Regulations will be needed, to limit parents on how they can modify their children and on how adults can modify themselves, to ensure the safe future of genetic engineering.